{
    "eid": "2-s2.0-85128219724",
    "title": "Clinical Utility of SCALE-B to Predict Hepatitis B Virus Relapse, Hepatitis B Surface Antigen Loss After Antiviral Cessation in Asian Patients After 2-Year Follow-up",
    "cover-date": "2022-03-24",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Medicine (all)",
            "@code": "2700",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "cessation",
        "clinical relapse (CR)",
        "hepatitis B core-related antigen (HBcrAg)",
        "hepatitis B surface antigen (HBsAg)",
        "hepatitis B virus ribonucleic acid (HBV RNA)",
        "nucleos(t)ide analogues (NAs)",
        "S-loss",
        "SCALE-B"
    ],
    "authors": [
        "Apichat Kaewdech",
        "Suraphon Assawasuwannakit",
        "Pimsiri Sripongpun",
        "Naichaya Chamroonkul",
        "Pisit Tangkijvanich",
        "Teerha Piratvisuth"
    ],
    "citedby-count": 3,
    "ref-count": 36,
    "ref-list": [
        "Hepatitis B virus: advances in prevention, diagnosis, and therapy",
        "Hepatitis B virus infection",
        "Serum HBsAg decline during long-term potent nucleos(t)ide analogue therapy for chronic hepatitis B and prediction of HBsAg loss",
        "Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: finite treatment duration unlikely",
        "Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update",
        "EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection",
        "Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance",
        "Challenges in the discontinuation of chronic hepatitis B antiviral agents",
        "Hepatitis B surface antigen, core-related antigen and HBV RNA: predicting clinical relapse after NA therapy discontinuation",
        "Prediction of sustained response after nucleo(s)tide analogue cessation using HBsAg and HBcrAg levels: a multicenter study (CREATE)",
        "Incidence and predictors of hepatitis B surface antigen seroclearance after cessation of nucleos(t)ide analogue therapy in hepatitis B e antigen-negative chronic hepatitis B",
        "Off-therapy durability of response to entecavir therapy in hepatitis B e antigen-negative chronic hepatitis B patients",
        "The role of hepatitis B surface antigen in nucleos(t)ide analogues cessation among asian patients with chronic hepatitis B: a systematic review",
        "Measurement of hepatitis B virus core-related antigen as predicting factor for relapse after cessation of lamivudine therapy for chronic hepatitis B virus infection",
        "Low serum level of hepatitis B core-related antigen indicates unlikely reactivation of hepatitis after cessation of lamivudine therapy",
        "Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk",
        "Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound",
        "Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessation",
        "Association between negative results from tests for HBV DNA and RNA and durability of response after discontinuation of nucles(t)ide analogue therapy",
        "Serum hepatitis B virus RNA: a new potential biomarker for chronic hepatitis B virus infection",
        "Predictors of hepatitis B surface antigen loss, relapse and retreatment after discontinuation of effective oral antiviral therapy in noncirrhotic HBeAg-negative chronic hepatitis B",
        "Reverse transcriptase droplet digital PCR vs reverse transcriptase quantitative real-time PCR for serum HBV RNA quantification",
        "APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients",
        "Discontinuation of oral antivirals in chronic hepatitis B: a systematic review",
        "Finite nucleos(t)ide analog therapy in HBeAg-negative chronic hepatitis B: an emerging paradigm shift",
        "Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stop long-term treatment with adefovir",
        "Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients \u2013 FINITE study",
        "Off-therapy response after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B: an international, multi-center, multi-ethnic cohort (RETRACT-B study)",
        "Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study",
        "Predictors of relapse after cessation of nucleos(t)ide analog treatment in HBeAg-negative chronic hepatitis B patients: a meta-analysis",
        "Novel viral markers and the prediction of off-treatment relapse in chronic hepatitis B patients: a systematic review",
        "Distinct relapse rates and risk predictors after discontinuing tenofovir and entecavir therapy",
        "Contrasting timing of virological relapse after discontinuation of tenofovir or entecavir in hepatitis B e antigen\u2013negative patients",
        "Combining hepatitis B virus RNA and hepatitis B core-related antigen: guidance for safely stopping nucleos(t)ide analogues in hepatitis B e antigen-positive patients with chronic hepatitis B",
        "The distribution of hepatitis B virus genotypes in Thailand",
        "HBsAg kinetics in retreatment decision for off-therapy hepatitis B flare in HBeAg-negative patients"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hatyai",
            "@id": "60025527",
            "affilname": "Faculty of Medicine, Prince of Songkia University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025527",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hatyai",
            "@id": "60006314",
            "affilname": "Prince of Songkla University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006314",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60000316",
            "affilname": "Srinakharinwirot University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000316",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Thai Association",
        "Faculty of Medicine, Prince of Songkla University"
    ]
}